Zimmermann, Heiner http://orcid.org/0000-0002-4242-275X
Nitsche, Mirko
Pott, Christiane
Reinke, Petra
Babel, Nina
Hermann, Robert M.
Hauser, Ingeborg A.
Hahn, Dennis
Ritgen, Matthias
Pietschmann, Claudia
Klapper, Wolfram
Anagnostopoulos, Ioannis
Trappe, Ralf U.
,
Funding for this research was provided by:
Roche Germany
Article History
Received: 5 March 2021
Accepted: 1 May 2021
First Online: 11 May 2021
Declarations
:
: The German PTLD registry was approved by the appropriate Ethics committees.
: Patients provided informed consent to the German PTLD registry according to the Declaration of Helsinki.
: Dr. Zimmermann reports institutional grants from Atara and Roche, and travel support from Atara, Celgene, and Jansen, outside the submitted work. Dr. Hauser reports personal fees or travel support from Astellas, Biotest, Hexal, Neovii, Novartis, and Roche, all outside the submitted work. Dr. Ritgen reports personal fees from Hoffman LaRoche, AbbVie, AstraZeneca, and Jansen, all outside the submitted work. Claudia Pietschmann reports travel support by KS Pharma, outside the submitted work. Dr. Trappe reports institutional grants from Atara and Roche and non-financial support from Roche, Atara, Celgene, Janssen, and AbbVie, all outside the submitted work. All other authors declare no competing interests.